The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Discovery and Optimization of a Natural HIV-1 Entry Inhibitor Targeting the gp41 Fusion Peptide
Open accessAbstract
A variety of molecules in human blood have been implicated in the inhibition of HIV-1. However, it remained elusive which circulating natural compounds are most effective in controlling viral replication in vivo. To identify natural HIV-1 inhibitors we screened a comprehensive peptide library generated from human hemofiltrate. The most potent fraction contained a 20-residue peptide, designated VIRUS-INHIBITORY PEPTIDE (VIRIP), corresponding to the C-proximal region of alpha1-antitrypsin, the most abundant circulating serine protease inhibitor. We found that VIRIP inhibits a wide variety of HIV-1 strains including those resistant to current antiretroviral drugs. Further analysis demonstrated that VIRIP blocks HIV-1 entry by interacting with the gp41 fusion peptide and showed that a few amino acid changes increase its antiretroviral potency by two orders of magnitude. Thus, as a highly specific natural inhibitor of the HIV-1 gp41 fusion peptide, VIRIP may lead to the development of another class of antiretroviral drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid phase peptide synthesis utilizing 9‐fluorenylmethoxycarbonyl amino acids
FIELDS, G. B., & NOBLE, R. L. (1990) · International Journal of Peptide and Protein Research · doi:10.1111/j.1399-3011.1990.tb00939.x · Cited by 2,493
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
Geijtenbeek, T. B. H., Kwon, D. S., Torensma, R., van Vliet, S. J., van Duijnhoven, G. C. F., Middel, J., Cornelissen, I. L. M. H. A., Nottet, H. S. L. M., KewalRamani, V. N., Littman, D. R., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)80694-7 · Cited by 2,447
HUMAN PLASMA PROTEINASE INHIBITORS
Travis, J., & Salvesen, G. S. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.003255 · Cited by 2,104
CD8 + Lymphocytes Can Control HIV Infection in Vitro by Suppressing Virus Replication
Walker, C. M., Moody, D. J., Stites, D. P., & Levy, J. A. (1986) · Science · doi:10.1126/science.2431484 · Cited by 990
Kilby, J. M., Hopkins, S., Venetta, T. M., DiMassimo, B., Cloud, G. A., Lee, J. Y., Alldredge, L., Hunter, E., Lambert, D., Bolognesi, D., et al. (1998) · Nature Medicine · doi:10.1038/3293 · Cited by 987
A trimeric structural domain of the HIV-1 transmembrane glycoprotein
Lu, M., Blacklow, S. C., & Kim, P. S. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb1295-1075 · Cited by 701
Stoller, J. K., & Aboussouan, L. S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66781-5 · Cited by 695
Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gpl60
Hallenberger, S., Bosch, V., Angliker, H., Shaw, E., Klenk, H.-D., & Garten, W. (1992) · Nature · doi:10.1038/360358a0 · Cited by 582
Matrix metalloproteinases in immunity
Goetzl, E. J., Banda, M. J., & Leppert, D. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.1.1 · Cited by 544
Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target
Chan, D. C., Chutkowski, C. T., & Kim, P. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15613 · Cited by 477
Stevenson, M. (2003) · Nature Medicine · doi:10.1038/nm0703-853 · Cited by 441
Determinants of Human Immunodeficiency Virus Type 1 Resistance to gp41-Derived Inhibitory Peptides
Rimsky, L. T., Shugars, D. C., & Matthews, T. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.986-993.1998 · Cited by 423
Protein Design of an HIV-1 Entry Inhibitor
Root, M. J., Kay, M. S., & Kim, P. S. (2001) · Science · doi:10.1126/science.1057453 · Cited by 391
HIV-1 Reverse Transcription A Termination Step at the Center of the Genome
Charneau, P., Mirambeau, G., Roux, P., Paulous, S., Buc, H., & Clavel, F. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1542 · Cited by 388
[35] The acute phase response: An overview
Kushner, I. (1988) · Methods in Enzymology · doi:10.1016/0076-6879(88)63037-0 · Cited by 306
Resistance to enfuvirtide, the first HIV fusion inhibitor
Greenberg, M. L. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh330 · Cited by 258
Liu, S., Lu, H., Niu, J., Xu, Y., Wu, S., & Jiang, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411141200 · Cited by 220
Self-citationInhibition of HIV-1 gp160-dependent membrane fusion by a furin-directed alpha 1-antitrypsin variant.
Anderson, E. D., Thomas, L., Hayflick, J. S., & Thomas, G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74548-7 · Cited by 212
New targets for inhibitors of HIV-1 replication
Moore, J. P., & Stevenson, M. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036060 · Cited by 167
Alpha‐1‐antitrypsin inhibits human immunodeficiency virus type 1
SHAPIRO, L., B. POTT, G., & H. RALSTON, A. (2001) · The FASEB Journal · doi:10.1096/fj.00-0311com · Cited by 161
Jiang, S., Kang, L., & Lu, M. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.10213-10217.1998 · Cited by 153
Self-citationA critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides
Helmerhorst, E. J., Reijnders, I. M., Hof, W. V. ‘., et al. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00411-1 · Cited by 151
θ-Defensins Prevent HIV-1 Env-mediated Fusion by Binding gp41 and Blocking 6-Helix Bundle Formation
Gallo, S. A., Wang, W., Rawat, S. S., Jung, G., Waring, A. J., Cole, A. M., Lü, H., Yan, X., Daly, N. L., Craik, D. J., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602422200 · Cited by 134
Self-citationDetheux, M., Ständker, L., Vakili, J., Münch, J., Forssmann, U., Adermann, K., Pöhlmann, S., Vassart, G., Kirchhoff, F., Parmentier, M., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.10.1501 · Cited by 132
Self-citationEckstein, D. A., Sherman, M. P., Penn, M. L., Chin, P. S., De Noronha, C. M. C., Greene, W. C., & Goldsmith, M. A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.10.1407 · Cited by 124
HIV-1 Coreceptors and Their Inhibitors
Ray, N., & Doms, R. W. (2007) · Springer eBooks · doi:10.1007/978-3-540-33397-5_5 · Cited by 99
Proteolytic inactivation of alpha-1-proteinase inhibitor by a neutrophil metalloproteinase.
Desrochers, P. E., & Weiss, S. J. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113500 · Cited by 99
Johnston, J. B., Jiang, Y., van Marle, G., Mayne, M. B., Ni, W., Holden, J. K., McArthur, J. C., & Power, C. (2000) · Journal of Virology · doi:10.1128/jvi.74.16.7211-7220.2000 · Cited by 93
Peptide bank generated by large-scale preparation of circulating human peptides
Schulz‐Knappe, P., Schrader, M., Ständker, L., Richter, R., Hess, R., Jürgens, M., & Forssmann, W. G. (1997) · Journal of Chromatography A · doi:10.1016/s0021-9673(97)00152-0 · Cited by 75
Self-citationHIV-1 resistance to the gp41-dependent fusion inhibitor C-34
Armand‐Ugón, M., Gutiérrez, A., Clotet, B., & Esté, J. A. (2003) · Antiviral Research · doi:10.1016/s0166-3542(03)00071-8 · Cited by 62
Münch, J., Ständker, L., Pöhlmann, S., Baribaud, F., Papkalla, A., Rosorius, O., Stauber, R. H., Sass, G., Heveker, N., Adermann, K., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.982-990.2002 · Cited by 34
Self-citationMembrane-Perturbing Domains of HIV Type 1 Glycoprotein 41
Mobley, P. W., Pilpa, R. M., Brown, C., Waring, A. J., & Gordon, L. M. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/08892220150503681 · Cited by 22
Miyazaki, Y., Kuwata, T., Takehisa, J., et al. (2002) · AIDS Research and Human Retroviruses · doi:10.1089/088922202753614236 · Cited by 2
Cited by
Anti-inflammatory Agents: Present and Future
Dinarello, C. A. (2010) · Cell · doi:10.1016/j.cell.2010.02.043 · Cited by 1,095
Historical insights into cytokines
Dinarello, C. A. (2007) · European Journal of Immunology · doi:10.1002/eji.200737772 · Cited by 926
Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme
White, J. M., Delos, S. E., Brecher, M., & Schornberg, K. (2008) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230802058320 · Cited by 892
Semen-Derived Amyloid Fibrils Drastically Enhance HIV Infection
Münch, J., Rücker, E., Ständker, L., Adermann, K., Goffinet, C., Schindler, M., Wildum, S., Chinnadurai, R., Rajan, D., Specht, A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.014 · Cited by 543
Self-citationBiosensor technology: recent advances in threat agent detection and medicine
Kirsch, J., Siltanen, C., Zhou, Q., Revzin, A., & Simonian, A. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60141b · Cited by 462
Metadata
- Authors
- Münch, J., Ständker, L., Adermann, K., Schulz, A., Schindler, M., Chinnadurai, R., Pöhlmann, S., Chaipan, C., Biet, T., Peters, T., Meyer, B., Wilhelm, D., Lu, H., Jing, W., Jiang, S., Forssmann, W.-G., & Kirchhoff, F.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2007-04
- Volume
- 129
- Issue
- 2
- Pages
- 263-275
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2026361605
- Cited by
- 261
- References
- 33
- FWCI
- 7.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.